Free Newsletter
Diabetes drugs linked to fracture risk
One more strike against diabetes drugs. Australia's regulators are warning that the class of drugs including Avandia and Actos may boost the risk of bone fractures in older women.
A four-year study of 4,360 patients showed that post-menopausal women taking one of the thiazolidinediones were more likely to break a bone. The Therapeutic Goods Administration won't withdraw the drugs, but manufacturers are warning doctors about the newly identified risks.
- read the report from the Sydney Morning Herald
Related Articles:
Avandia, Actos don't boost death risk. Report
Actos on a good-news roll. Report
Avandia risks back in the headlines. Report
Australia bans Novartis' Prexige. Report
Comments
Post new comment
Paid Research Reports
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
- Optimizing Lifecycle Management: Maximizing commercial lifespan through label expansion and combination products
- The CRO Market Outlook: Emerging markets, leading players and future trends
- Pharmaceutical Sales Force Effectiveness Strategies
- Commercial Insight: Influenza Vaccines and Antivirals - The pandemic's long-term impact





